Results 61 to 70 of about 254,454 (341)

Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study [PDF]

, 2019
Neuromyelitis optica spectrum disorders lack imaging biomarkers associated with disease course and supporting prognosis. This complex and heterogeneous set of disorders affects many regions of the central nervous system, including the spinal cord and ...
Asseyer, Susanna, Bellmann-Strobl, Judith, Brandt, Alexander U., Chien, Claudia, Kuchling, Joseph, Oertel, Frederike Cosima, Paul, Friedemann, Ruprecht, Klemens, Scheel, Michael, Siebert, Nadja, Zimmermann, Hanna   +10 more
core   +2 more sources

Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients

BioImpacts, 2012
Soheila Rezapour-Firouzi, Seyed Rafie Arefhosseini, Mehdi Farhoudi, Mehrangiz Ebrahimi‐Mameghani, Mohammad‐Reza Rashidi, Mohammadali Torbati, Behzad Baradaran   +6 more
openalex   +3 more sources

Inflammatory Activity on Natalizumab Predicts Short-term but not Long-term Disability in Multiple Sclerosis [PDF]

, 2017
BACKGROUND: In people with multiple sclerosis treated with interferon-beta or glatiramer acetate, new MRI lesions and relapses during the first year of treatment predict a poor prognosis.
Dahdaleh, S, Gafson, AR, Jones, B, Malik, O, Nicholas, R, Raffel, J   +5 more
core   +1 more source

Apolipoprotein E Polymorphism Interacts with Cigarette Smoking in Progression of Multiple Sclerosis [PDF]

, 2009
BACKGROUND AND PURPOSE: The influence of apolipoprotein E (ApoE) polymorphism on clinical severity of multiple sclerosis (MS) is still controversial. Cigarette smoking has been suggested to influence the progression of disability in these patients.
Andrade, ML, Araujo, C, Cascais, MJ, Couderc, R, Ferret-Sena, V, Morais, MG, Pedrosa, R, Roque, R, Sena, A   +8 more
core   +1 more source

The Framingham cardiovascular risk score in multiple sclerosis [PDF]

, 2015
Background and purpose: Cardiovascular risk factors can increase the risk of multiple sclerosis (MS) and modify its course. However, such factors possibly interact, determining a global cardiovascular risk.
BRESCIA MORRA, VINCENZO, Caporale, O., Carotenuto, A., DE ROSA, ANNA, LANZILLO, ROBERTA, Maniscalco, G. T., Massarelli, M., Moccia, M, Palladino, R., Postiglione, E., Russo, C., TRIASSI, MARIA   +11 more
core   +1 more source

Influence of FK 506 (tacrolimus) on circulating CD4 ⁺ t cells expressing cd25 and cd45ra antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial [PDF]

, 1994
We have taken the opportunity of a clinical trial of the potential efficacy and safety of FK 506 (tacrolimus) in chronic progressive multiple sclerosis (MS) to examine the influence of this potent new immunosuppressant on circulating T-lymphocytes in an ...
A. W. Thomson, Abu-Elmagd K., B. Eidelman, B. Lemster, Collett D, Eidelman B H., Ellison G W., Emry P., Fung J J., H. R. Rilo, Hafler D A., Hafler D A., Hauser S L., Hintzen R Q., Hofman F M., J. J. Fung, J. Woo, Japanese FK, K. Abu-Elmagd, Kino T., Kurtzke J F, L. L. Huang, Lebranchu Y., Lemster B., Lemster B., McCauley J., McMichael J., Mochizuki M., Mortimoto C, N. Johnson, P. B. Carroll, R. Russell-Hall, Rose L M., Starzl T E., T. E. Starzl, Tamura K., The Multiple Sclerosis Study Group, Thomson A V., Thomson A W, Thomson A W., Thomson A W., Thomson A W., Tocci M J., W. Irish, Woo J., Woo J., Zeevi A.   +46 more
core   +1 more source

Silent progression in disease activity-free relapsing multiple sclerosis. [PDF]

, 2019
ObjectiveRates of worsening and evolution to secondary progressive multiple sclerosis (MS) may be substantially lower in actively treated patients compared to natural history studies from the pretreatment era.
Baranzini, Sergio E, Barba, Patrick, Bevan, Carolyn, Bischof, Antje, Bove, Riley, Caverzasi, Eduardo, Cree, Bruce AC, Gelfand, Jeffrey M, Gomez, Refujia, Goodin, Douglas S, Graves, Jennifer, Green, Ari J, Gundel, Tristan, Hauser, Stephen L, Henry, Roland G, Hollenbach, Jill A, Kirkish, Gina, Oksenberg, Jorge R, Papinutto, Nico, Ragan, Nicholas R, Romeo, Andrew, Rush, Gillian Q, Sacco, Simone, Santaniello, Adam, Stern, William A, University of California, San Francisco MS-EPIC Team, Wilson, Michael R, Zamvil, Scott S, Zhao, Chao, Zhu, Alyssa H   +29 more
core   +1 more source

Apelin-13: A promising biomarker for multiple sclerosis?

Annals of Indian Academy of Neurology, 2018
Objectives: Recent studies have shown that Apelin 13 may have a neuroprotective property. Therefore it can be used as a biomarker for multiple sclerosis.
Murat Alpua, Yakup Turkel, Ersel Dag, Ucler Kisa   +3 more
doaj   +1 more source

Physical therapy for a patient with neuromyelitis optica during the acute phase: A case report

SAGE Open Medical Case Reports, 2021
The aim of this report was to examine the safety of physical therapy for hemiplegia in a patient with neuromyelitis optica in the acute phase. A 32-year-old female with neuromyelitis optica diagnosed by magnetic resonance imaging had a T2-weighted ...
Yuichi Nishikawa, Noriaki Maeda, Hiroaki Kimura   +2 more
doaj   +1 more source

The Role of Trace elements in Multiple Sclerosis.

مجلة كلية الطب, 2014
Fac Med Baghdad 2014; Vol.56, No.2 Received: Feb., 2014 Accepted April. 2014     Background:  Multiple sclerosis (MS)  is a  chronic,  demyelinating disease  of  the central nervous system (CNS) affecting young adults and is
Ammar A. Thamer, Najeeb H. Mohammed, Akram M. Ibrahim   +2 more
doaj   +1 more source